Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Cancer ; 60(5): 668-75, 1995 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-7532159

RESUMO

Invasion of basement membranes is a key step in systemic spread of tumour cells. To analyze genetic mechanisms involved in this process, we have selected strongly and weakly invasive sublines with stable phenotypes from a primary human melanoma cell line by repeated passage through a reconstituted basement membrane in vitro. The sublines differed approximately 5-fold in their invasive potential. Invasiveness correlated with better attachment and overexpression of the integrin alpha v/beta 3 (vitronectin/laminin-receptor). Treatment with retinoic acid inhibited proliferation in both sublines and invasion in the weakly invasive cells but stimulated invasion in the strongly invasive subline. Northern-blot analyses revealed equal levels of mRNA expression regarding collagenase type-IV and retinoic-acid receptors but enhanced expression of TIMP-2 mRNA in weakly invasive cells. The 2 sublines differed significantly in their respective DNA ploidy when compared to the wild-type Mel Im cell line, suggesting that they represent heterogeneous clones present in the primary tumour. We have started to exploit this in vitro system for tumour heterogeneity to clone genes involved in invasion. By a subtractive cDNA cloning strategy, 12 partial cDNA clones were obtained that are specifically overexpressed in the strongly or weakly invasive subline. These results illustrate that stable genetic alterations lead to heterogeneous subpopulations within primary melanomas which differ in their ability to invade basement membranes and interact with components of the extracellular matrix.


Assuntos
DNA Complementar/isolamento & purificação , DNA de Neoplasias/isolamento & purificação , Regulação Neoplásica da Expressão Gênica , Melanoma/patologia , Invasividade Neoplásica/patologia , Proteínas de Neoplasias/genética , Neoplasias Cutâneas/patologia , Actinas/biossíntese , Actinas/genética , Aneuploidia , Células Clonais/patologia , Clonagem Molecular , Colágeno , Colagenases/biossíntese , Colagenases/genética , DNA Complementar/genética , DNA de Neoplasias/genética , Progressão da Doença , Combinação de Medicamentos , Humanos , Integrinas/biossíntese , Integrinas/genética , Laminina , Melanoma/genética , Invasividade Neoplásica/genética , Proteínas de Neoplasias/biossíntese , Biossíntese de Proteínas , Proteínas/genética , Proteoglicanas , Receptores de Citoadesina/biossíntese , Receptores de Citoadesina/genética , Receptores de Vitronectina , Seleção Genética , Neoplasias Cutâneas/genética , Inibidor Tecidual de Metaloproteinase-2 , Tretinoína/farmacologia , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA